Plasma Citrulline Level in Relation to Absorptive Surface

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00286039

Enrollment

200

Registered

2006-02-02

Start date

2005-08-31

Completion date

2010-09-30

Last updated

2021-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal Failure

Brief summary

Correlation between determination of citrulline in plasma or dried blood Reference ranges for healthy children and babies Longitudinal follow-up of citrulline in preterm babies

Interventions

PROCEDUREBlood sampling

Blood sampling is used.

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

No minimum to 18 Years

Healthy volunteers

Inclusion criteria

* 0-18 years * preterm babies up to 1.500g * preterm babies over 1.500g

Exclusion criteria

* gastro-intestinal problems (except for the preterm babies) * congenital metabolic disorders * dysfunction of the liver or kidneys * congenital defects

Design outcomes

Primary

Measure	Time frame
Correlation between determination of citrulline in plasma or dried blood	Untill end of study
Reference ranges for healthy children and babies	Until end of study
Longitudinal follow-up of citrulline in preterm babies	Untill end of study

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026